176.57 USD
-6.04 (-3.31%)
176.57 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to ICLR. ICLR was compared to 57 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ICLR get a neutral evaluation. Nothing too spectacular is happening here. ICLR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- ICLR had positive earnings in the past year.
- ICLR had a positive operating cash flow in the past year.
- In the past 5 years ICLR has always been profitable.
- ICLR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.63%, ICLR is in the better half of the industry, outperforming 75.44% of the companies in the same industry.
- ICLR has a Return On Equity of 6.42%. This is in the better half of the industry: ICLR outperforms 75.44% of its industry peers.
- With a decent Return On Invested Capital value of 6.74%, ICLR is doing good in the industry, outperforming 75.44% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for ICLR is significantly below the industry average of 13.75%.
- The last Return On Invested Capital (6.74%) for ICLR is above the 3 year average (5.80%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROIC | 6.74% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
1.3 Margins
- ICLR has a Profit Margin of 7.40%. This is in the better half of the industry: ICLR outperforms 75.44% of its industry peers.
- In the last couple of years the Profit Margin of ICLR has declined.
- ICLR's Operating Margin of 13.99% is fine compared to the rest of the industry. ICLR outperforms 73.68% of its industry peers.
- In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
- The Gross Margin of ICLR (28.15%) is worse than 77.19% of its industry peers.
- ICLR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% |
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICLR is destroying value.
- The number of shares outstanding for ICLR has been reduced compared to 1 year ago.
- The number of shares outstanding for ICLR has been increased compared to 5 years ago.
- The debt/assets ratio for ICLR has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.06 indicates that ICLR is not a great score, but indicates only limited risk for bankruptcy at the moment.
- ICLR has a Altman-Z score (2.06) which is in line with its industry peers.
- ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
- ICLR's Debt to FCF ratio of 3.53 is fine compared to the rest of the industry. ICLR outperforms 78.95% of its industry peers.
- A Debt/Equity ratio of 0.31 indicates that ICLR is not too dependend on debt financing.
- ICLR has a Debt to Equity ratio (0.31) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Altman-Z | 2.06 |
ROIC/WACC0.76
WACC8.88%
2.3 Liquidity
- ICLR has a Current Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
- ICLR has a worse Current ratio (1.06) than 84.21% of its industry peers.
- A Quick Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
- The Quick ratio of ICLR (1.06) is worse than 77.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
- The earnings per share for ICLR have decreased by -5.99% in the last year.
- ICLR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.23% yearly.
- ICLR shows a decrease in Revenue. In the last year, the revenue decreased by -2.46%.
- Measured over the past years, ICLR shows a very strong growth in Revenue. The Revenue has been growing by 24.17% on average per year.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
3.2 Future
- The Earnings Per Share is expected to grow by 5.27% on average over the next years.
- Based on estimates for the next years, ICLR will show a small growth in Revenue. The Revenue will grow by 2.38% on average per year.
EPS Next Y-4.69%
EPS Next 2Y-1.27%
EPS Next 3Y2.47%
EPS Next 5Y5.27%
Revenue Next Year-2.43%
Revenue Next 2Y-1.03%
Revenue Next 3Y0.73%
Revenue Next 5Y2.38%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- ICLR is valuated correctly with a Price/Earnings ratio of 13.39.
- Compared to the rest of the industry, the Price/Earnings ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 96.49% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.94, ICLR is valued rather cheaply.
- With a Price/Forward Earnings ratio of 12.94, ICLR is valued correctly.
- Based on the Price/Forward Earnings ratio, ICLR is valued cheaper than 96.49% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.94, ICLR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.39 | ||
| Fwd PE | 12.94 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ICLR is valued cheaply inside the industry as 98.25% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, ICLR is valued cheaper than 96.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.98 | ||
| EV/EBITDA | 10.79 |
4.3 Compensation for Growth
- The decent profitability rating of ICLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.88
EPS Next 2Y-1.27%
EPS Next 3Y2.47%
5. Dividend
5.1 Amount
- No dividends for ICLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
176.57
-6.04 (-3.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners105.53%
Inst Owner Change0.07%
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap13.48B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts75
Price Target208.97 (18.35%)
Short Float %3.48%
Short Ratio2.82
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)-0.4%
PT rev (3m)-5.06%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)-4.62%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-1.1%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)1.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.39 | ||
| Fwd PE | 12.94 | ||
| P/S | 1.66 | ||
| P/FCF | 13.98 | ||
| P/OCF | 11.82 | ||
| P/B | 1.44 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.79 |
EPS(TTM)13.19
EY7.47%
EPS(NY)13.65
Fwd EY7.73%
FCF(TTM)12.63
FCFY7.15%
OCF(TTM)14.93
OCFY8.46%
SpS106.11
BVpS122.25
TBVpS-38.98
PEG (NY)N/A
PEG (5Y)0.88
Graham Number190.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 6.98% | ||
| ROICexgc | 176.34% | ||
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% | ||
| FCFM | 11.9% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 45.31% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.92% | ||
| Profit Quality | 160.84% | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 2.06 |
F-Score6
WACC8.88%
ROIC/WACC0.76
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-4.69%
EPS Next 2Y-1.27%
EPS Next 3Y2.47%
EPS Next 5Y5.27%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.43%
Revenue Next 2Y-1.03%
Revenue Next 3Y0.73%
Revenue Next 5Y2.38%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year1.2%
EBIT Next 3Y1.96%
EBIT Next 5Y4.34%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%
ICON PLC / ICLR FAQ
Can you provide the ChartMill fundamental rating for ICON PLC?
ChartMill assigns a fundamental rating of 5 / 10 to ICLR.
What is the valuation status for ICLR stock?
ChartMill assigns a valuation rating of 6 / 10 to ICON PLC (ICLR). This can be considered as Fairly Valued.
How profitable is ICON PLC (ICLR) stock?
ICON PLC (ICLR) has a profitability rating of 6 / 10.
What is the valuation of ICON PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ICON PLC (ICLR) is 13.39 and the Price/Book (PB) ratio is 1.44.
How financially healthy is ICON PLC?
The financial health rating of ICON PLC (ICLR) is 5 / 10.